In fact, the tumor sphere formation ability was decreased, and the levels of a panel of established CSC markers, including CD133, CD44, Sox2, Oct4, Nanog, and ALDH1A1, were decreased in colon cancer cells treated with GM‐Exo subjected to S100A9 knockdown. The gene discussed is ALDH1A1; the disease is neoplasm.